Jazz Pharmaceuticals plc — Director's Dealing 2010

Mar 10, 2010

SEC Form 4/A — Form 4/A

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2009-11-13

Reporting Person: SEBULSKY ALAN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-11-13	Common Stock	P	2256	$6.85	Acquired	20720	Direct
2009-11-13	Common Stock	P	7532	$6.84	Acquired	28252	Direct

Footnotes

F1: On November 17, 2010, a voluntary Form 4 was filed and incorrectly stated the number of shares of common stock beneficially owned following the reported transaction. Accordingly, this amendment is being filed solely to correct the error in the original Form 4.